| 10/3/2023 | 30021500000 | Fisher Clinical Services GmbH (TM) STC: CLINICAL TRIAL MEDICINES (MK3475 IP1 3475 587 3475 V4 25MG/ML 4ML/VL 2VL M1) QTY: 2 PCS | XXXXXXXXXX | 0 | NA | 4554 | GERMANY | N/A |
| 7/25/2023 | 30021500000 | HARMLESS MEDICINES CIZUMAB 400MG 2 PCS | XXXXXXXXXX | 0 | NA | 584.17 | INDIA | N/A |
| 7/12/2023 | 30021500000 | FISHER CLINICAL SERVICES PTE LTD (TM) STC: CLINICAL TRIAL MEDICINES (MK3475 25MG/ML 4ML/VIAL 2 VIALS /KIT ) QTY: 3 PCS | XXXXXXXXXX | 0 | NA | 7294.8 | SINGAPORE | N/A |
| 6/29/2023 | 30021500000 | FISHER CLINICAL SERVICES PTE LTD (TM) STC: CLINICAL TRIAL MEDICINES (MK3475 25MG/ML 4ML/VIAL 2 VIALS /KIT) QTY: 3 PCS | XXXXXXXXXX | 0 | NA | 7226.62 | SINGAPORE | N/A |
| 4/24/2023 | 30021500000 | FISHER CLINICAL SERVICES (TM) STC: CLINICAL TRIAL MEDICINES (PEMBROLIZUMAB MK3475 100MG/4ML SOLUTION FOR INTRAVENOUS INFUSION) QTY: 2 KITS | XXXXXXXXXX | 0 | NA | 5269.66 | United Kingdom | N/A |
| 4/14/2023 | 30021500000 | FISHER CLINICAL SERVICES PTE LTD (TM) STC: CLINICAL TRIAL MEDICINES (3475 B15 ENFORTUMAB VEDOTIN 30MG VL M2) QTY: 16 KITS | XXXXXXXXXX | 0 | NA | 2453.37 | SINGAPORE | N/A |
| 4/14/2023 | 30021500000 | FISHER CLINICAL SERVICES PTE LTD (TM) STC: CLINICAL TRIAL MEDICINES (3475 B15 3475 V1 2MG/ML 4ML/VL 2VL M2) QTY: 4 KITS | XXXXXXXXXX | 0 | NA | 9908.18 | SINGAPORE | N/A |
| 4/3/2023 | 30021500000 | FISHER CLINICAL SERVICES GB (TM) STC: CLINICAL TRIAL MEDICINES (ENFORTUMAB VEDOTIN (ASG-22CE)30MG LYOPHILIZED POWDER FOR RECONSTITUTION) QTY: 12 KITS | XXXXXXXXXX | 0 | NA | 2127.86 | United Kingdom | N/A |
| 4/3/2023 | 30021500000 | FISHER CLINICAL SERVICES GB(TM) STC: CLINICAL TRIAL MEDICINES (Enfortumab Vedotin(ASG-22CE)30mg Lyophilized Powder for Reconstitution) QTY: 12 KITS | XXXXXXXXXX | 0 | NA | 2127.86 | United Kingdom | N/A |